SCHEMBL10094673

SCHEMBL10094673

Cc1ccc(F)cc1-c1ccccc1C#N

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 0.47
AR P10275 3/20 0.44
ESR2 Q92731 1/20 0.40
NR3C1 P04150 1/20 0.39
GRIN1 Q05586 1/20 0.38
GRIN2B Q13224 1/20 0.38
NISCH Q9Y2I1 1/20 0.37
HPGD P15428 2/20 0.36
KDM4E B2RXH2 1/20 0.36
GALR3 O60755 1/20 0.36
ALDH1A1 P00352 1/20 0.36
GAA P10253 1/20 0.36
PDE2A O00408 1/20 0.36
PDE10A Q9Y233 1/20 0.36
USP8 P40818 1/20 0.36
USP7 Q93009 1/20 0.36
LMNA P02545 1/20 0.36
GABRG2 P18507 1/20 0.36
GABRB3 P28472 1/20 0.36
GABRA5 P31644 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1133478 0.82 TSHR (0.50) TSHRARESR2HPGDKDM4E
SCHEMBL29993589 0.82 TSHR (0.50) TSHRARESR2HPGDKDM4E
SCHEMBL21022649 0.82 ESR2 (0.44) TSHRARESR2NR3C1USP8
SCHEMBL21020725 0.79 PLA2G7 (0.57) TSHRARESR2HPGDKDM4E
SCHEMBL1472952 0.79 TSHR (0.67) TSHRARESR2HPGDKDM4E
SCHEMBL10304929 0.79 CYP1A2 (0.45) TSHRNISCHHPGDKDM4EALDH1A1
SCHEMBL19579050 0.78 ESR2 (0.44) TSHRARESR2NR3C1USP8
SCHEMBL20076355 0.78 HSP90AB1 (0.37) ARUSP8USP7GABRG2GABRB3
SCHEMBL30377758 0.77 NISCH (0.52) NISCHPDE2APDE10ALMNALRRK2
SCHEMBL9139591 0.77 NISCH (0.52) NISCHPDE2APDE10ALMNALRRK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8148535-B2 Potassium channel inhibitors MERCK SHARP & DOHME CORP. (US) 2012-04-03 US disclosed
US-20090233897-A1 Potassium Channel Inhibitors MERCK SHARP & DOHME CORP. 2009-09-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090233897-A1 Potassium Channel Inhibitors KCNJ2, KCNQ2, KCNH2 TSHR 2897/4885AR 4159/4885ESR2 3957/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.